Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma

Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma

BackgroundDrug-induced immune hemolytic anemia (DIIHA) is a rare but potentially life-threatening drug-related complication. There are no previous reports of pemetrexed plus cisplatin as first-line chemotherapy for non-small cell lung cancer, resulting in DIIHA.Case presentationIn this report, a pat...

Full description

Bibliographic Details
Main Authors: Hongkai Lu, Na Wang, Peng Wang, Haolin Zhang, Ru Zhao, Hongju Liu, Xirong He, Zeya Liu, Yue Chang, Yongtong Cao, Shiyao Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Medicine
Subjects:
pemetrexed
cisplatin
complement-dependent antibody
non-immunologic protein adsorption
drug-induced immune hemolytic anemia
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.917485/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.917485/full

Similar Items